Del Mar, CA, United States of America

Sandy T Feldman

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Sandy T Feldman: Innovator in Ophthalmic Treatments

Introduction

Sandy T Feldman is a prominent inventor based in Del Mar, California, known for her significant contributions to ophthalmic treatment technologies. With a total of 10 patents to her name, she has made remarkable advancements in the field of eye care.

Latest Patents

Among her latest patents is an ophthalmic treatment device, system, and method of use. This innovative system includes a light source device, at least one optical treatment head operatively coupled to the light source device, and a light control device. The treatment light promotes corneal and/or scleral collagen cross-linking, enhancing the effectiveness of eye treatments. Another notable patent involves compositions and methods for treating or preventing diseases associated with oxidative stress. This pharmaceutical composition utilizes sodium iodide or catalase to mitigate oxidative stress in patients, showcasing her commitment to improving health outcomes.

Career Highlights

Sandy has worked with several companies, including CXL Ophthalmics, LLC and Epion Therapeutics, Inc. Her work in these organizations has been instrumental in developing cutting-edge ophthalmic solutions that address various eye conditions.

Collaborations

Throughout her career, Sandy has collaborated with notable professionals in the field, including Roy S Rubinfeld and Raymond A Hartman. These partnerships have further enriched her innovative endeavors and contributed to her success as an inventor.

Conclusion

Sandy T Feldman stands out as a leading figure in ophthalmic innovation, with her patents reflecting her dedication to advancing eye care technologies. Her work continues to impact the field positively, paving the way for future advancements in ophthalmic treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…